Sunday, May 9, 2021

Cipla to make, sell Eli Lilly's baricitinib to treat Covid-19

Baricitinib has been given restricted emergency use approval by India's drug regulator for use in combination with remdesivir for the treatment of hospitalised Covid-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2RJlsOw
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

In a viral video, over 3,000 engineers were seen queuing outside a Pune-based company for a recent walk-in drive targeting junior developer ...